ALNY (Alnylam) Kompaniyaning xususiy kapitali

Ommaviy kompaniya alnylam.com (ALNY) logotipi

Alnylam Pharmaceuticals (ALNY) tor doiradagi RNK terapiyasi platformasiga tayanadi va kardiologiya segmentiga kengayish orqali konsentratsiya risklarini kamaytirmoqda, bu GURU.Markets platformasidagi 1.37 darajasidagi joriy narx harakatlarida aks etgan. Alnylam Pharmaceuticals (ALNY) global ustunlikka intilib, tor doiradagi ishlanmalarni ommaviy bozor blokbasterlariga aylantirmoqda. Texnologik jarayon robotlashtirilgan ishlab chiqarishni algoritmik modellashtirish bilan birlashtiradi, ammo yakuniy sinov bosqichi tibbiyot mutaxassislarining mas'uliyatida qolmoqda.

ALNY Alnylam Pharmaceuticals, Inc.: Kompaniyaning balans qiymati 04.07.2022 - 29.10.2026 oraligʻida

Alnylam - tahliliy kesimlar va asosiy koʻrsatkichlar (ALNY)

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Aksiya kursi Alnylam Corp|ALNY - Konsensus maqsadli narx
- biznesning bozor baholash ko'rsatkichlari:
Bozor qiymati Alnylam Pharmaceuticals, Inc.|ALNY - Kompaniyaning to‘liq qiymati
- kompaniyaning balans qiymati tafsilotlari:
Aksiya hisobiga sof aktivlar Alnylam|ALNY - Kompaniyaning balans qiymati|Sof aktivlarga nisbatan bozor kapitallashuvi alnylam.com|ALNY - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Alnylam Pharmaceuticals|ALNY - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Alnylam Pharmaceuticals, Inc.|ALNY - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Alnylam Pharmaceuticals, Inc.|ALNY - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Alnylam|Tezkor likvidlik alnylam.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ALNY - Sof foyda
Kompaniyaning fundamental baholanishi:ALNY (Alnylam Corp)
Alnylam Inc. asosiy tovari

Alnylam Pharmaceuticals (ALNY) kompaniyasining RNK interferensiyasi sohasidagi strategik ittifoqlari barqarorligi biznesning moddiy bazasida bevosita aks etgan. Ushbu ko'rsatkich bozor tebranishlarini hisobga olmagan holda, barcha aktivlar va majburiyatlar o'rtasidagi farqni aniqlaydi. Kompaniyaning balans qiymatini tahlil qilish orqali investor sof resurslarning haqiqiy hajmini ko'rishi mumkin. Ushbu raqamning o'sishi dori vositalarining muvaffaqiyatli tijoratlashtirilganini tasdiqlaydi, qiymatlarning pasayishi esa tadqiqot va ishlanmalarga haddan tashqari ko'p mablag' sarflanganidan dalolat berishi mumkin.

Alnylam Pharmaceuticals raqobatchilari tahlili

VRTX (Vertex Corp) - Buxgalteriya kapitallashuvi|INSM (Insmed Incorporated) - Kompaniyaning sof aktivlari|Kompaniyaning xususiy kapitali unither.com (UTHR)|Kompaniyaning balans qiymati BioMarin|BridgeBio Pharma (BBIO) - Biznesning balans bahosi|Kompaniyaning balans qiymati BGM Group Ltd (BGM)|COGT: Sof aktivlar qiymati|Balans kapitallashuvi XERS (Xeris Biopharma)|kerostx.com (KROS) - Kompaniyaning xususiy kapitali|Arcturus Therapeutics Holdings Inc. - Balans kapitallashuvi|Eton Pharmaceuticals Inc (ETON) - Kompaniyaning sof aktivlari|KMDA: Balans kapitallashuvi|FULC - Biznesning balans bahosi|ABEO (Abeona Therapeutics, Inc.) - Balans kapitallashuvi|Balans kapitallashuvi Mereo BioPharma Group PLC|Kompaniyaning balans qiymati Protalix BioTherapeutics, Inc. (PLX)|Kompaniyaning balans qiymati PLRX (pliantrx.com)|Balans kapitallashuvi APLT (Applied Therapeutics, Inc.)|Biznesning balans bahosi Aileron Therapeutics (RNTX)|GELS: Kompaniyaning sof aktivlari|Sof aktivlar qiymati AYTU|CMMB: Balans kapitallashuvi|Kompaniyaning xususiy kapitali SRx Health Solutions (SRXH)|PLRZ (Polyrizon Limited) - Balans kapitallashuvi|Buxgalteriya kapitallashuvi AEZS (Zentaris)|Kompaniyaning sof aktivlari CYTH (Cyclo Therapeutics)|INZY (inozyme.com) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Reneo Pharmaceuticals, Inc. RPHM|CSCI (COSCIENS Biopharma Inc) - Sof aktivlar qiymati